First Impression: CSL (CSL) Interim Result

Bell Potter


Business Units: CSL Behring and Sequirius revenue up 17%, EBIT up 30% (Outperformance in Immunoglobulins and Specialty Products (Berinert). Seqirus (Flu) sales and EBIT were better than anticipated.) | Net operating cash flow down 5.8% to US$664.2m | Outlook: CSL Group’s net profit after tax (NPAT) is expected to grow in the range of approximately 18 to 20% at constant currency. (Increased FX headwinds to -US$50m (from –US$35m). “Earnings per share (EPS) are again expected to exceed profit growth.”


1 stock mentioned

Bell Potter Securities is a leading Australian stockbroking, investment and financial advisory firm that provides a comprehensive offering of financial services to a diversified client base that includes individuals, institutions and corporations.

I would like to

Only to be used for sending genuine email enquiries to the Contributor. Livewire Markets Pty Ltd reserves its right to take any legal or other appropriate action in relation to misuse of this service.

Personal Information Collection Statement
Your personal information will be passed to the Contributor and/or its authorised service provider to assist the Contributor to contact you about your investment enquiry. They are required not to use your information for any other purpose. Our privacy policy explains how we store personal information and how you may access, correct or complain about the handling of personal information.